Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 98446-49-2
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS No:: |
98446-49-2 |
Appearance:: |
Pale Brown Solid |
Molecular Formula:: |
C7H7Cl2NO |
Molecular Weight:: |
192.04 |
EINECS NO:: |
619-345-9 |
MDL NO.:: |
MFCD00974410 |
CAS No:: |
98446-49-2 |
Appearance:: |
Pale Brown Solid |
Molecular Formula:: |
C7H7Cl2NO |
Molecular Weight:: |
192.04 |
EINECS NO:: |
619-345-9 |
MDL NO.:: |
MFCD00974410 |
Product Description:
Product Name:2,4-Dichloro-5-m ethoxyaniline CAS 98446-49-2
Synonyms:
4,6-Dichloro-m-anisidine;
5-AMINO-4,6-DICHLOROANISOLE;
BENZENAMINE,2,4-DICHLORO-5-M ETHOXY-.
Chemical & Physical Properties
Appearance:Pale Brown Solid
Assay: NLT98%
Melting Point:51 °C
Boiling point:290.1±35.0 °C
Density:1.375±0.06 g/cm3
Solubility:Chloroform (Slightly), Methanol (Slightly)
Safety Information
Risk Statements:R20/21/22
Hazard Codes:Xi,Xn
HS Code:2922290090
Application:2,4-Dichloro-5-m ethoxyaniline is mainly used in the preparation of bosutinib intermediate 4-[(2,4-dichloro-5-m ethoxyphenyl)amino]-6-met hoxy -7-(3-Chloropropoxy)-3-quinolinecarbonitrile.Bosutinib, developed by Wyeth Pharmaceuticals of the United States, was approved by the European Union as an "orphan drug" in September 2010 for the treatment of chronic myelogenous leukemia (CML).On September 4, 2012, the drug was approved by the U.S. Food and Drug Administration (FDA) for marketing under the trade name Bosulif.It was approved for marketing by the European Food and Drug Administration (EMA) on March 27, 2013, and approved by Japan's PMDA on September 26, 2014.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.